Altered endosomal-lysosomal biogenesis in melanoma

Area of Science:

• Oncology
• Molecular Biology
• Dermatology

Background:

• Cutaneous melanoma, the deadliest skin cancer, necessitates early detection to reduce mortality.
• Current detection methods relying on melanin visualization struggle to differentiate between benign and malignant lesions, especially amelanotic melanomas.
• The endosomal-lysosomal system plays a critical role in cancer cell biology and melanosome biogenesis, a key factor in melanoma pathogenesis.

Purpose of the Study:

• To investigate the involvement of the endosomal-lysosomal system in cutaneous melanoma.
• To identify differentially expressed endosomal-lysosomal genes and potential protein markers for distinguishing melanoma subtypes and predicting malignant potential.

Main Methods:

• Pooled secondary analysis of existing gene expression datasets.
• Identification of differentially expressed endosomal-lysosomal genes.
• Immunohistochemistry on patient samples to validate protein expression of candidate markers.

Main Results:

• A set of interconnected, differentially expressed endosomal-lysosomal genes was identified in melanoma.
• Dysregulation of Syntenin-1, Sortilin, and Rab25 may differentiate cutaneous melanoma from squamous cell carcinoma.
• IGF2R expression may indicate malignant propensity in skin cancers.

Conclusions:

• The endosomal-lysosomal system is significantly dysregulated in cutaneous melanoma.
• Candidate markers including Syntenin-1, Sortilin, Rab25, and IGF2R show potential for improving skin cancer diagnosis and prognostication.